These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28534862)

  • 1. Differences in Gene Expression Profiles between Early and Late Isolates in Monospecies Achromobacter Biofilm.
    Nielsen SM; Meyer RL; Nørskov-Lauritsen N
    Pathogens; 2017 May; 6(2):. PubMed ID: 28534862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motility, Biofilm Formation and Antimicrobial Efflux of Sessile and Planktonic Cells of
    Nielsen SM; Penstoft LN; Nørskov-Lauritsen N
    Pathogens; 2019 Jan; 8(1):. PubMed ID: 30691200
    [No Abstract]   [Full Text] [Related]  

  • 3. Patterns of virulence factor expression and antimicrobial resistance in Achromobacter xylosoxidans and Achromobacter ruhlandii isolates from patients with cystic fibrosis.
    Pereira RH; Leão RS; Carvalho-Assef AP; Albano RM; Rodrigues ER; Firmida MC; Folescu TW; Plotkowski MC; Bernardo VG; Marques EA
    Epidemiol Infect; 2017 Feb; 145(3):600-606. PubMed ID: 27873565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncovering Differences in Virulence Markers Associated with Achromobacter Species of CF and Non-CF Origin.
    Filipic B; Malesevic M; Vasiljevic Z; Lukic J; Novovic K; Kojic M; Jovcic B
    Front Cell Infect Microbiol; 2017; 7():224. PubMed ID: 28611955
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic Airway Colonization by Achromobacter xylosoxidans in Cystic Fibrosis Patients Is Not Sustained by Their Domestic Environment.
    Dupont C; Jumas-Bilak E; Doisy C; Aujoulat F; Chiron R; Marchandin H
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217850
    [No Abstract]   [Full Text] [Related]  

  • 6. Outbreak of Achromobacter xylosoxidans in an Italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains.
    Trancassini M; Iebba V; Citerà N; Tuccio V; Magni A; Varesi P; De Biase RV; Totino V; Santangelo F; Gagliardi A; Schippa S
    Front Microbiol; 2014; 5():138. PubMed ID: 24772108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exoproducts of the Most Common
    Sahl C; Baumgarten M; Shannon O; Påhlman LI
    Microbiol Spectr; 2023 Aug; 11(4):e0019523. PubMed ID: 37284754
    [No Abstract]   [Full Text] [Related]  

  • 8. Genomic and Phenotypic Evolution of Achromobacter xylosoxidans during Chronic Airway Infections of Patients with Cystic Fibrosis.
    Khademi SMH; Gabrielaite M; Paulsson M; Knulst M; Touriki E; Marvig RL; Påhlman LI
    mSystems; 2021 Jun; 6(3):e0052321. PubMed ID: 34184916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Efflux in Antibiotic Resistance of
    Chalhoub H; Kampmeier S; Kahl BC; Van Bambeke F
    Front Microbiol; 2022; 13():762307. PubMed ID: 35418957
    [No Abstract]   [Full Text] [Related]  

  • 10.
    Firmida MC; Marques EA; Leão RS; Pereira RH; Rodrigues ER; Albano RM; Folescu TW; Bernardo V; Daltro P; Capone D; Lopes AJ
    Respir Med Case Rep; 2017; 20():98-103. PubMed ID: 28138423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achromobacter Species Isolated from Cystic Fibrosis Patients Reveal Distinctly Different Biofilm Morphotypes.
    Nielsen SM; Nørskov-Lauritsen N; Bjarnsholt T; Meyer RL
    Microorganisms; 2016 Sep; 4(3):. PubMed ID: 27681927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of the species of Achromobacter in a French Cystic Fibrosis Centre and multilocus sequence typing analysis reveal the predominance of A. xylosoxidans and clonal relationships between some clinical and environmental isolates.
    Amoureux L; Bador J; Bounoua Zouak F; Chapuis A; de Curraize C; Neuwirth C
    J Cyst Fibros; 2016 Jul; 15(4):486-94. PubMed ID: 26778615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic characterization of
    Veschetti L; Sandri A; Patuzzo C; Melotti P; Malerba G; Lleo MM
    Microb Genom; 2021 Jul; 7(7):. PubMed ID: 34292148
    [No Abstract]   [Full Text] [Related]  

  • 14. Longitudinal Surveillance and Combination Antimicrobial Susceptibility Testing of Multidrug-Resistant
    Okoliegbe IN; Hijazi K; Cooper K; Ironside C; Gould IM
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32816722
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of the
    Le Goff M; Vastel M; Lebrun R; Mansuelle P; Diarra A; Grandjean T; Triponney P; Imbert G; Gosset P; Dessein R; Garnier F; Durand E
    Front Cell Infect Microbiol; 2022; 12():859181. PubMed ID: 35782124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation.
    Lobo LJ; Tulu Z; Aris RM; Noone PG
    Transplantation; 2015 Oct; 99(10):2196-202. PubMed ID: 25856407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achromobacter xylosoxidans is the predominant Achromobacter species isolated from diverse non-respiratory samples.
    Amoureux L; Bador J; Verrier T; Mjahed H; DE Curraize C; Neuwirth C
    Epidemiol Infect; 2016 Dec; 144(16):3527-3530. PubMed ID: 27535588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Full characterization of plasmids from Achromobacter ruhlandii isolates recovered from a single patient with cystic fibrosis (CF).
    Steffanowski C; Papalia M; Iriarte A; Langleib M; Galanternik L; Gutkind G; Cooper V; Ramírez MS; Radice M
    Rev Argent Microbiol; 2022; 54(1):3-8. PubMed ID: 33896603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Evolution of
    Silva IN; Santos PM; Santos MR; Zlosnik JE; Speert DP; Buskirk SW; Bruger EL; Waters CM; Cooper VS; Moreira LM
    mSystems; 2016; 1(3):. PubMed ID: 27822534
    [No Abstract]   [Full Text] [Related]  

  • 20. Achromobacter spp. prevalence and adaptation in cystic fibrosis lung infection.
    Veschetti L; Boaretti M; Saitta GM; Passarelli Mantovani R; Lleò MM; Sandri A; Malerba G
    Microbiol Res; 2022 Oct; 263():127140. PubMed ID: 35931003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.